Pharming provides update on outstanding shares – MarketWatch (press release)Filed Under: Antibody Mediated Rejection, cadaver
|
Pharming provides update on outstanding shares
MarketWatch (press release) The product is also under development for follow-on indications, ie antibody-mediated rejection (AMR) and delayed graft function (DGF) following kidney … |
- Read More
- 6 Aug 2010 1:59 AM
- Comments (0)